Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ANL · against 483 other Healthcare companies of similar size
Ranked #436 of 484 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score166 peers with a valuation score of 0–9, including ANL · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | ANL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 471 reported | -6.9% | 0.8% | 26% | 30% | |
| EBITDA yieldHigher is better · 488 reported | -5.3% | 3.7% | 22% | 50% | |
| Free cash flow yieldHigher is better · 205 reported | Not reported | -4.3% | — | — | 20% |
| Book yieldHigher is better · 483 reported | 34.8% | 45.6% | 36% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 436 | 7.2B CNY (≈$1.0B) | 0 | 34 | |
| 436 | 2.9B CNY (≈$408M) | 0 | 37 | |
| 436 | 337M USD | 0 | 33 | |
| 436 | 1.0B USD | 0 | 35 | |
| 436 | 617M USD | 0 | 28 | |
| 436 | 336M USD | 0 | 43 | |
| 436 | 1.2B USD | 0 | ||
| 436 | 1.2B USD | 0 | 3 | |
| 436 | 555M EUR (≈$611M) | 0 | 25 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score